Compugen (CGEN) Other Operating Expenses (2009 - 2026)
Compugen recorded quarterly Other Operating Expenses of $134000.0 in Q1 2026, down 3.6% quarter-over-quarter from $139000.0 in Q1 2025, and down 3.6% year-over-year from $139000.0 in Q1 2025.
Compugen's Other Operating Expenses history runs 2 years deep, the most recent figure standing at $134000.0 for Q1 2026.
- In Q1 2026, Other Operating Expenses fell 3.6% year-over-year to $134000.0; the TTM figure through Mar 2026 stood at $273000.0 (up 96.4% YoY), while the FY2013 annual figure was $962000.0, up 40.64% from the prior year.
- Other Operating Expenses came in at $134000.0 for Q1 2026 at Compugen, down from $139000.0 in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $139000.0 in Q1 2025 to a low of $134000.0 in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Compugen | 234.03 Mn | 142.28 Mn | 352,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 134,000.00 |
| Dec 31, 2025 | 120,000.00 |
| Sep 30, 2025 | 139,000.00 |
| Jun 30, 2025 | 141,000.00 |
| Mar 31, 2025 | 139,000.00 |
| Dec 31, 2024 | 167,000.00 |
| Sep 30, 2024 | 161,000.00 |
| Jun 30, 2024 | 157,000.00 |
| Mar 31, 2024 | 91,000.00 |
| Dec 31, 2023 | 61,000.00 |
| Sep 30, 2023 | 18,000.00 |
| Jun 30, 2023 | 49,000.00 |
| Mar 31, 2023 | 116,000.00 |
| Dec 31, 2022 | 191,000.00 |
| Sep 30, 2022 | 263,000.00 |
| Jun 30, 2022 | 255,000.00 |
| Mar 31, 2022 | 223,000.00 |
| Dec 31, 2021 | 211,000.00 |
| Sep 30, 2021 | 166,000.00 |
| Jun 30, 2021 | 241,000.00 |
| Mar 31, 2021 | 224,000.00 |
| Dec 31, 2020 | 238,000.00 |
| Sep 30, 2020 | 219,000.00 |
| Jun 30, 2020 | 204,000.00 |
| Mar 31, 2020 | 210,000.00 |
| Dec 31, 2019 | 159,000.00 |
| Sep 30, 2019 | 104,000.00 |
| Jun 30, 2019 | 175,000.00 |
| Mar 31, 2019 | 213,000.00 |
| Dec 31, 2018 | 245,000.00 |
| Sep 30, 2018 | 692,000.00 |
| Jun 30, 2018 | 319,000.00 |
| Mar 31, 2018 | 378,000.00 |
| Dec 31, 2017 | 291,000.00 |
| Sep 30, 2017 | 289,000.00 |
| Jun 30, 2017 | 283,000.00 |
| Mar 31, 2017 | 326,000.00 |
| Dec 31, 2016 | 433,000.00 |
| Sep 30, 2016 | 270,000.00 |
| Jun 30, 2016 | 199,000.00 |
| Mar 31, 2016 | 272,000.00 |
| Dec 31, 2015 | 564,000.00 |
| Sep 30, 2015 | 267,000.00 |
| Jun 30, 2015 | 248,000.00 |
| Mar 31, 2015 | 230,000.00 |
| Dec 31, 2014 | 400,000.00 |
| Sep 30, 2014 | 156,000.00 |
| Jun 30, 2014 | 109,000.00 |
| Mar 31, 2014 | 173,000.00 |
| Dec 31, 2013 | 195,000.00 |
| Sep 30, 2013 | 415,000.00 |
| Jun 30, 2013 | 157,000.00 |
| Mar 31, 2013 | 195,000.00 |
| Dec 31, 2012 | 186,000.00 |
| Sep 30, 2012 | 147,000.00 |
| Jun 30, 2012 | 156,000.00 |
| Mar 31, 2012 | 195,000.00 |
| Dec 31, 2011 | 114,000.00 |
| Sep 30, 2011 | 198,000.00 |
| Jun 30, 2011 | 150,000.00 |
| Mar 31, 2011 | 100,000.00 |
| Dec 31, 2010 | 98,000.00 |
| Sep 30, 2010 | 168,000.00 |
| Jun 30, 2010 | -345,000.00 |
| Mar 31, 2010 | 188,000.00 |
| Dec 31, 2009 | -226,000.00 |
| Sep 30, 2009 | -5,000.00 |
| Jun 30, 2009 | -155,000.00 |
| Mar 31, 2009 | 123,000.00 |